期刊文献+

XAF1增加TRAIL诱导的肝癌细胞凋亡的敏感性 被引量:3

XAF1 Increases the Sensitivity of TRAIL-induced Apoptosis in Hepatocellular Carcinoma Cells
下载PDF
导出
摘要 背景:肿瘤坏死因子(TNF)相关凋亡诱导配体(TRAIL)可特异性诱导肿瘤细胞凋亡,但部分肿瘤细胞对TRAIL不敏感甚至耐药。目的:探讨X连锁凋亡抑制蛋白(XIAP)相关因子1(XAF1)是否可增加TRAIL诱导的肝癌细胞株凋亡的敏感性。方法:重组人TRAIL(rhTRAIL)因子分别加入3株肝癌细胞株SMMC7721、HepG2和Bel-7404中培养,联合或不联合相同感染复数(MOI)的重组腺病毒Ad5/F35-XAF1和对照空病毒Ad5/F35-Null。作用48h后,以MTT检测细胞活力,以AnnexinV—FITC/PI法检测细胞凋亡率。结果:随着TRAIL浓度的增加,3株肝癌细胞株的细胞活力均不同程度降低。TRAIL与Ad5/F35-XAFI联合作用后,其细胞活力显著低于单独TRAIL组,而Ad5/F35-Null组细胞活力与单独TRAIL组无明显差异。与空白对照组和Ad5/F35-Null组相比.TRAIL组和Ad5/F35-XAF1组3株肝癌细胞株的凋亡率均显著增加。TRAIL与Ad5/F35-XAF1联合作用后.细胞凋亡率显著高于Ad5/F35-XAF1组或TRAIL组。结论:XAF1可明显增加TRAIL诱导的肝癌细胞凋亡的敏感性.两者联合应用对诱导不同肝癌细胞凋亡具有协同作用。 Background: Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) can specifically induce apoptosis of tumor cells, but a portion of tumor cells are less sensitive or even resistant to TRAIL. Aims: To investigate the effect of X-linked inhibitor of apoptosis protein (XIAP)-associated factor 1 (XAF1) on sensitizing TRAIL-induced apoptosis of hepatocellular carcinoma cell lines. Methods: Recombinant human TRAIL (rhTRAIL) was co-cultured with 3 hepatocellular carcinoma cell lines SMMC7721, HepG2 and Bel-7404, with or without the addition of recombinant adenovirus AdS/F35-XAF1 or control empty virus AdS/F35-Null at the same multiplicity of infection (MOI). MTT assay was used to evaluate cell viability. Cell apoptosis was determined by Annexin V-FITC/PI. Results: With the increasing concentration of TRAIL, cell viability of 3 hepatoeellular carcinoma cell lines was decreased in all groups. Compared with TRAIL group, cell viability of 3 hepatocellular carcinoma cell lines was significantly decreased when TRAIL was combined with AdS/F35-XAF1, but no significant differeuce was found between TRAIL group and TRAIL combined with AdS/F35-Null group. The apoptosis rates of 3 hepatocellular carcinoma cell lines were significantly increased in TRAIL group and AdS/F35-XAF1 group than those in control empty group and AdS/F35-Null group. Compared with AdS/F35- XAF1 group or TRAIL group, cell apoptosis was rapidly enhanced when TRAIL combined with AdS/F35-XAF1. Conclusions: XAF1 may increase the sensitivity of TRAIL-induced cell apoptosis. Combined use of XAF1 and TRAIL may have synergistic effect on inducing the apoptosis of hepatocellular carcinoma cells.
出处 《胃肠病学》 2010年第6期344-347,共4页 Chinese Journal of Gastroenterology
基金 国家自然科学基金(30572142) 上海市卫生局青年科研项目(2009Y402)资助
关键词 XIAP相关因子1 TNF相关凋亡诱导配体 肝肿瘤 细胞凋亡 XIAP-Associated Factor 1 TNF-Related Apoptosis-lnducing Ligand Liver Neoplasms Apoptosis
  • 相关文献

参考文献17

  • 1Ashkenazi A,Pai RC,Fong S,et al.Safety and antitumor activity of recombinant soluble Apo2 ligand.J Clin Invest,1999,104(2):155-162.
  • 2Han C,Song JH,Hsi B,et al.TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice.Cancer Res,2004,64(23):8502-8506.
  • 3Lawrence D,Shahrokh Z,Marsters S,et al.Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions.Nat Med,2001,7(4):383-385.
  • 4Sadarangani A,Kato S,Espinoza N,et al.TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract.Apoptosis,2007,12(1):73-85.
  • 5Van Geelen CM,de Vries EG,de Jong S.Lessons from TRAIL-resistance mechanisms in colorectal cancer cells:paving the road to patient-tailored therapy.Drug Resist Updat,2004,7(6):345-358.
  • 6Bhojani MS,Rossú BD,Rehemtulla A.TRAIL and antitumor responses.Cancer Biol Ther,2003,2(4 Suppl 1):S71-S78.
  • 7Koschny R,Walczak H,Ganten TM.The promise of TRAIL--potential and risks of a novel anticancer therapy.J Mol Med,2007,85(9):923-935.
  • 8Tu SP,Liston P,Cui JT,et al.Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer.Int J Cancer,2009,125(3):688-697.
  • 9朱黎明,涂水平,姚玮艳,乔敏敏,江石湖.腺病毒介导XAF1基因诱导人肝癌细胞株SMMC7721凋亡的实验研究[J].胃肠病学,2009,14(2):74-78. 被引量:8
  • 10张晨莉,朱黎明,涂水平,戴强,姚玮艳,谭继宏,乔敏敏,江石湖.XAF1基因在肝癌细胞凋亡中的诱导作用[J].胃肠病学,2009,14(12):730-733. 被引量:1

二级参考文献45

  • 1史冬梅,马天乐,涂水平,谭继宏,乔敏敏,章永平,江石湖.X-染色体相关凋亡抑制蛋白相关因子1抑制肝癌细胞增殖和诱导凋亡的实验研究[J].中华消化杂志,2006,26(10):682-685. 被引量:13
  • 2Liston P, Fong WG, Kelly NL, et al. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol, 2001, 3 (2): 128-133.
  • 3Fong WG, Liston P, Rajcan-Separovic E, et al. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics, 2000, 70 (1): 113-122.
  • 4Ma TL, Ni PH, Zhong J, et al. Low expression of XIAP- associated factor 1 in human colorectal cancers. Chin J Dig Dis, 2005, 6 (1): 10-14.
  • 5Byun DS, Cho K, Ryu BK, et al. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res, 2003, 63 (21): 7068-7075.
  • 6Fang X, Liu Z, Fan Y, et al. Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor. Int J Cancer, 2006, 118 (10): 2485-2489.
  • 7Zou B, Chim CS, Zeng H, et al. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology, 2006, 131 (6): 1835-1843.
  • 8Lee MG, Huh JS, Chung SK, et al. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses. Oncogene, 2006, 25 (42): 5807-5822.
  • 9Lind GE, Thorstensen L, Lφvig T, et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer, 2004, 3: 28.
  • 10Kempkensteffen C, Hinz S, Schrader M, et al. Gene expression and promoter methylation of the XIAP- associated factor 1 in renal cell carcinomas: correlations with pathology and outcome. Cancer Lett, 2007, 254 (2): 227-235.

共引文献16

同被引文献28

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部